Current reports
6-K
Shangpharma Corporation Announces Completion of Merger
28 Mar 13
6-K
Shangpharma Corporation Announces Shareholders’ Approval of Merger Agreement
20 Mar 13
6-K
Shangpharma Corporation Announces Extraordinary General
25 Feb 13
6-K
Shangpharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction
26 Dec 12
6-K
ShangPharma Announces Third Quarter 2012 Results
23 Nov 12
6-K
Current report (foreign)
13 Nov 12
6-K
ShangPharma Announces Second Quarter 2012 Results
27 Aug 12
6-K
ShangPharma Independent Committee Appoints Financial Advisor
3 Aug 12
6-K
ShangPharma Independent Committee Appoints Chairman and Legal Counsel
17 Jul 12
6-K
ShangPharma Announces Receipt of “Going Private” Proposal at $8.50 to $9.50 Per ADS
6 Jul 12
Registration and prospectus
15-12B
Securities registration termination
15 Apr 13
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 13
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 13
25-NSE
Exchange delisting
3 Apr 13
SC 13E3/A
Going private transaction (amended)
28 Mar 13
SC 13E3/A
Going private transaction (amended)
25 Feb 13
SC 13E3/A
Going private transaction (amended)
31 Jan 13
SC 13E3
Going private transaction
31 Dec 12
S-8
Registration of securities for employees
16 Dec 11
S-8
Registration of securities for employees
25 Feb 11
Proxies
No filings
Ownership
SC 13D/A
TPG Group Holdings (SBS) Advisors, Inc.
2 Apr 13
SC 13D/A
Hui Michael Xin
2 Apr 13
SC 13D/A
ShangPharma Holdings Ltd
2 Apr 13
SC 13D/A
Hui Michael Xin
27 Feb 13
SC 13D/A
ShangPharma Holdings Ltd
26 Feb 13
SC 13D/A
TPG Group Holdings (SBS) Advisors, Inc.
26 Feb 13
SC 13D
ShangPharma Holdings Ltd
26 Dec 12
SC 13D/A
TPG Group Holdings (SBS) Advisors, Inc.
26 Dec 12
SC 13D/A
Hui Michael Xin
26 Dec 12
SC 13D
TPG Group Holdings (SBS) Advisors, Inc.
16 Jul 12